Due to changes in sales rights for blockbuster items that are frequently dispensed, the pharmaceutical supply and demand are expected to be affected in the end-of-year period and early 2025.

According to the pharmaceutical distributor industry on November 26, several pharmaceutical companies are expected to change their distributors at the end of this year or early next year.

Medication with confirmed changes to sales rights is Pfizer's Viviant Tab. Pfizer Korea has recently sent an official letter to wholesale distributors, hospitals, and pharmacies notifying 'The changes to the supply chain for Viviant.'

Pfizer stated in the official letter that Pfizer will be r